GSA CAPITAL PARTNERS LLP - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$744,000
+148.0%
106,172
+193.0%
0.11%
+180.0%
Q1 2022$300,000
+85.2%
36,241
+51.5%
0.04%
+100.0%
Q4 2021$162,000
+18.2%
23,928
+0.3%
0.02%
+33.3%
Q2 2021$137,000
-67.3%
23,855
-73.8%
0.02%
-78.6%
Q1 2021$419,000
+24.7%
90,890
-9.7%
0.07%
+27.3%
Q4 2020$336,000
+1.8%
100,605
+17.4%
0.06%
-33.7%
Q1 2020$330,000
-53.1%
85,680
-54.3%
0.08%
+1.2%
Q4 2019$703,000
+282.1%
187,496
+441.3%
0.08%
+228.0%
Q3 2019$184,000
+82.2%
34,638
+32.1%
0.02%
+127.3%
Q2 2019$101,000
-86.8%
26,220
-87.1%
0.01%
-73.8%
Q3 2018$767,000
-35.4%
202,845
-46.7%
0.04%
-28.8%
Q2 2018$1,187,000
+416.1%
380,605
+295.7%
0.06%
+391.7%
Q1 2018$230,000
-81.0%
96,196
-79.9%
0.01%
-85.4%
Q3 2017$1,208,000
+48.8%
479,196
-35.7%
0.08%
+86.4%
Q3 2016$812,000
+84.5%
745,077
+20.2%
0.04%
+83.3%
Q2 2016$440,000619,7770.02%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders